Lithium

ALBemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, today announced the pricing of an underwritten public offering of senior notes consisting of:

Albemarle Corp. Logo. (PRNewsFoto/Albemarle Corporation)

  • $650,000,000 of 4.650% senior notes due 2027,
  • $600,000,000 of 5.050% senior notes due 2032, and
  • $450,000,000 of 5.650% senior notes due 2052.

The notes will be Albemarle's general senior unsecured obligations. The gross proceeds from the offering are expected to be approximately $1.7 billion , before deducting the underwriting discounts and commissions and estimated offering expenses payable by Albemarle . The offering is expected to close on or about May 13, 2022 , subject to the satisfaction of customary closing conditions.

Albemarle intends to use a portion of the net proceeds from the offering to fund a redemption of its outstanding 4.15% senior notes due 2024, including the payment of the associated redemption premium. Albemarle intends to use the remaining net proceeds of the offering for general corporate purposes, including the repayment of outstanding commercial paper notes.

The joint book-running managers for the offering are BofA Securities, Inc., J.P. Morgan Securities LLC, and Mizuho Securities USA LLC. HSBC Securities ( USA ) Inc., MUFG Securities Americas Inc., SMBC Nikko Securities America, Inc., and US Bank, N.A. are also acting as additional joint book-running managers.

The senior notes described above are being offered by Albemarle pursuant to a shelf registration statement on Form S-3, including a base prospectus, that was previously filed by Albemarle with the Securities and Exchange Commission (SEC) and that became automatically effective on November 6, 2019 . The offering is being made only by means of a prospectus supplement and the accompanying base prospectus, which have been filed with the SEC and are available on the SEC's website located at http://www.sec.gov. Copies of the prospectus supplement and the accompanying prospectus relating to the offering may also be obtained from BofA Securities, Inc., by email at dg.prospectus_requests@bofa.com , Attention: Prospectus Department, or by telephone at 1-800-294-1322, J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions by telephone at 1-866-803-9204 and Mizuho Securities USA , LLC by telephone at 1-866-271-7403.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy the senior notes described above or any other security, nor shall there be any offer or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Albemarle Corporation
ALBemarle Corporation (NYSE: ALB) is a global specialty chemicals company with leading positions in lithium, bromine and catalysts. We think beyond business as usual to power the potential of companies in many of the world's largest and most critical industries, such as energy, electronics, and transportation. We actively pursue a sustainable approach to managing our diverse global footprint of world-class resources. In conjunction with our highly experienced and talented global teams, our deep-seated values, and our collaborative customer relationships, we create value-added and performance-based solutions that enable a safer and more sustainable future.

Forward-Looking Statements
Some of the information presented in this press release, including, without limitation, information regarding the terms of the public offering, the intended use of proceeds from the offering and the satisfaction of customary closing conditions with respect to the offering, and all other information relating to matters that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from the views expressed. Factors that could cause Albemarle's actual results to differ materially from the view expressed or implied in any forward-looking statement include, without limitation: changes in economic and business conditions; changes in financial and operating performance of its major customers and industries and markets served by it; the timing of orders received from customers; the gain or loss of significant customers; market correction in lithium market pricing; changes with respect to contract renegotiations; potential production volume shortfalls; competition from other manufacturers; changes in the demand for its products or the end-user markets in which its products are sold; limitations or prohibitions on the manufacture and sale of its products; availability of raw materials; increases in the cost of raw materials and energy, and its ability to pass through such increases to its customers; technological change and development, changes in its markets in general; fluctuations in foreign currencies; changes in laws and government regulation impacting its operations or its products; the occurrence of regulatory actions, proceedings, claims or litigation (including with respect to the U.S. Foreign Corrupt Practices Act and foreign anti-corruption laws); the occurrence of cyber-security breaches, terrorist attacks, industrial accidents or natural disasters, the effect of climate change, including any regulatory changes to which it might be subject; hazards associated with chemicals manufacturing; the inability to maintain current levels of insurance, including product or premises liability insurance, or the denial of such coverage; political unrest affecting the global economy, including adverse effects from terrorism or hostilities; political instability affecting our manufacturing operations or joint ventures; changes in accounting standards; the inability to achieve results from its global manufacturing cost reduction initiatives as well as its ongoing continuous improvement and rationalization programs; changes in the jurisdictional mix of its earnings and changes in tax laws and rates or interpretation; changes in monetary policies, inflation or interest rates that may impact its ability to raise capital or increase its cost of funds, impact the performance of its pension fund investments and increase its pension expense and funding obligations; volatility and uncertainties in the debt and equity markets; technology or intellectual property infringement, including cyber-security breaches, and other innovation risks; decisions it may make in the future; future acquisition and divestiture transactions, including the ability to successfully execute, operate and integrate acquisitions and divestitures and incurring additional indebtedness; continuing uncertainties as to the duration and impact of the coronavirus (COVID-19) pandemic; performance of Albemarle's partners in joint ventures and other projects; changes in credit ratings; and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under "Risk Factors" in Albemarle's most recent Annual Report on Form 10-K any subsequently filed Quarterly Reports on Form 10-Q. These forward-looking statements speak only as of the date of this press release. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/albemarle-announces-pricing-of-public-offering-of-senior-notes-301544705.html

SOURCE Albemarle Corporation

News Provided by PR Newswire via QuoteMedia

ALB
copper highlights

Benton Reports Results of Phase II Drilling at Far Lake Copper-Silver Project, Ontario

Benton Resources Inc. (TSXV: BEX) ("Benton" or "the Company") today announces results from the Phase II drilling program at its Far Lake Copper-Silver project located 80 km west of Thunder Bay, Ontario. The second phase of drilling at Far Lake totaled 2,696 m and was designed to test new areas associated with surface mineralization as well as various chargeability anomalies outlined by a deep, 3D IP geophysical survey. Highlights from this latest campaign include copper mineralization in the previously untested Centre Pond zone, intersected at a drill hole depth of 338 m (DDH FL-21-17).

Benton continues to be encouraged by the Cu mineralization identified in this intrusive complex and will continue to model the data collected for further targeting on the project. The Company is presently collecting up to 3,500 soil samples for multi-element analysis and is actively mapping and prospecting the property to generate further targets for drilling later this year. Geochemical anomalies identified in 2020 soil sampling led to the discovery at FL-20-11.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Cypress Development: Potential Long-Term Low-Cost Producer of Lithium in Nevada

Cypress Development: Potential Long-Term Low-Cost Producer of Lithium in Nevada

Cypress Development (TSXV:CYP, OTCQB:CYDVF) focuses on developing its 100 percent owned Clayton Valley lithium project in Nevada, USA. The company’s extensive exploration and development have led to discovering a world-class lithium-bearing claystone resource adjacent to the Albemarle (NYSE: ALB) Silver Peak mine, North America’s only lithium brine operation. The company’s discovery of the massive resource made Clayton Valley a premium American source of lithium that has the potential to impact the supply of lithium for the fast-growing energy storage battery market.

“We’re in Nevada and we’re in a country that badly needs lithium. We would be the most environmentally friendly project, and the lowest acid consumer. We’re able to eliminate sulfuric acid in our process and that would make us an extremely environmentally friendly, large, inexpensive low cost producer in the heart of the United States.” said Cypress Development CEO Dr. Bill Willoughby.

Keep reading...Show less
Sienna Update on Norway Gold Project

Sienna Update on Norway Gold Project

Sienna Resources Inc. (TSXV: SIE) (FSE: A1XCQ0) (OTC PINK: SNNAF) (the "Company") Sienna Resources is pleased to announce the commencement of field exploration at the Bleka Gold Project in Norway. The Bleka Vein was discovered in 1880 and mined intermittently until 1940, with historic production reported as 165 kilograms (i.e., ~ 5,300 troy ounces) of gold sourced from mineralized material with an average grade of 36 gt gold1.  The historic Bleka vein is hosted in a deformed greenstone belt in southern Norway and was formed during two phases of quartz-veining events. Auriferous quartz veins characteristically contain Cu-Bi and tourmaline2. Compilation of historic reports combined with reconnaissance mapping revealed a series of under-explored vein swarms on the Bleka property. Earlier this year, a systematic sampling program to test the vein swarms was initiated to identify gold-rich vein sets. Results were encouraging with over 10% of samples showing anomalous gold results (6 of 52 rockchip samples contained more than 0.1 ppm Au)3.  Historic reports show rock chip samples with similar quantities of anomalous results with some vein samples reaching up to 103 gt Au4.  As a result of this field work, previously unknown quartz veins were discovered and follow-up soil sampling is currently being conducted in an attempt to identify additional buried quartz veins.

Going forward Sienna has planned more surface sampling coupled with a planned UVA supported magnetic survey which will delineating important structural features to generate  high priority drill targets. Over the coming weeks the historic mine maps will be compiled to create 3D model of the known mineralization and drill planning will commence to test mineralized continuation down plunge and along strike from the existing mine workings.  SIE has not performed sufficient work to verify the published data reported above, but SIE believes this information is considered reliable and relevant.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
TSXV:SIE

Sienna Closes Flow-Through Financing

 Sienna Resources Inc. (TSXV: SIE) (FSE: A1XCQ0) (OTCBB: SNNAF) (the "Company") Sienna has closed its financing consisting of 2,222,222 flow-through shares for gross proceeds of $200,000. No warrants were issued in the financing. An aggregate finders' fee of $12,000 was paid in connection with the private placement. All the securities issued in connection with this private placement have a hold period that expires on February 17, 2021. Proceeds will be used towards the Company's planned work programs. The private placement is subject to final approval of the TSX Venture Exchange and was originally announced on October 14, 2020. Please refer to that news release.

This flow through will be allocated primarily for Sienna's Marathon North Platinum-Palladium Property in Northern Ontario directly bordering Generation Mining Ltd.'s (CSE: GENM) 7.1-million-ounce palladium-equivalent Marathon Deposit. Management cautions that past results or discoveries on properties in proximity to Sienna may not necessarily be indicative to the presence of mineralization on the Company's properties.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
CSE:CBII

CB2 Insights Selected by Vireo Health to Support Medical Cannabis Clinical Trial

Highlights:

  • CB2 chosen to advance application with the US FDA for study on safety and efficacy of cannabis-based topical treatments by leading multistate operator, Vireo.
  • Project marks the start of the clinical trial process for Vireo’s topical creams, lotions and gels to be used by patients for pain management.
  • Company will develop full protocols and manage Investigational New Drug (IND) application on behalf of Vireo and will work with the FDA towards approvals.
  • Vireo will also be licensing the Company’s Sail technology platform for full data collection to ensure structured, clean data availability when required.

CB2 Insights (CSE:CBII, OTCQB:CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, today announced it has partnered with Licensed Producer, Vireo Health International Inc. (“Vireo”) (CNSX:VREO, OTCQX:VREOF), to advance the proof of safety and efficacy for cannabinoid therapy as it relates to metered-dosing for patients with ailments in which cannabis-based medicine is believed to support. CB2 will oversee the protocol development and Investigational New Drug (IND) Application directly with the US Food & Drug Administration (FDA). The successful completion will position Vireo for industry leadership when it comes to cannabis-based topical medication used to treat pain. Vireo will also license the Company’s Sail technology platform for full data collection and management.

Keep reading...Show less
business people stacking wooden blocks

Australian Lithium Miners Post Quarterly Results as Fundamentals Remain Strong

After hitting all-time highs in 2021, lithium prices started to stabilise in 2022's first quarter.

China’s lockdown measures to battle COVID-19 have disrupted the supply chain and impacted domestic demand in recent weeks, but this is expected to be temporary, according to William Adams of Fastmarkets.

“The lithium market is very tight. We don't see that easing anytime soon,” he said during a recent webinar about risks in the battery metals market. “We think the underlying fundamentals and the trends are still very strong.”

Keep reading...Show less
Noram Lithium

Noram Lithium Engages Mayer and Associates

Sandy MacDougall, CEO of Noram LithiumCorp. ("Noram" or the "Company") (TSXV: NRM | OTCQB: NRVTF | Frankfurt: N7R) is pleased to report that it has engaged Mayer and Associates ("MASS") to assist the Company with its strategic partnerships and relationships, as well as a financing strategy. This will include the introduction of institutional investors, strategic analysts as well as reputable articles and interviewswith reputable entities. MASS is an arms-length consulting firm, based in New York, and specializing in operations and strategies of public and private companies.

MASS has been engaged for an initial term of twelve months. In consideration for the engagement, the Company will issue 50,000 common shares monthly (the "Consideration Shares").Assuming MASS completes the entire term of the engagement, they will receive a total of 600,000Consideration Shares.

Keep reading...Show less

Albemarle Corporation Announces Redemption of All Outstanding 4.150% Senior Notes Due 2024

ALBemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, today announced that it intends to redeem all its outstanding 4.150% Senior Notes due 2024 (CUSIP No. 012725 AC1, ISIN No. US012725AC13) (the "Notes") on June 12, 2022 (the "Redemption Date").

Albemarle Corp. Logo. (PRNewsFoto/Albemarle Corporation)

The Notes will be redeemed at a redemption price equal to the greater of (1) 100% of the principal amount of the Notes and (2) the sum of the present values of the remaining scheduled payments of principal and interest on the Notes (exclusive of interest accrued to the Redemption Date) from the Redemption Date through the Par Call Date, as defined in the Notes (assuming the Notes matured on the Par Call Date), in each case discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined in the Notes) plus 30 basis points, plus in each case, accrued and unpaid interest on the redeemed Notes to, but not including, the Redemption Date.

The Notes will be repaid with a portion of the net proceeds from Albemarle's offering of $1.7 billion aggregate principal amount of senior notes completed on May 13, 2022 .

Holders of any Notes in certificated form will be paid the Redemption Price upon presentation and surrender of their Notes for redemption at the address of the Trustee and Paying Agent indicated below.   Notes in book-entry form must be surrendered through the facilities of The Depository Trust Company in the usual manner, and payment of the Redemption Price will be made through the facilities of The Depository Trust Company in the usual manner.  Notes called for redemption must be so surrendered to collect the Redemption Price.

Albemarle has instructed U.S. Bank Trust Company, National Association, as the Trustee and Paying Agent for the Notes (the " Trustee "), to distribute a Notice of Redemption to all registered holders of the Notes on or about May 13, 2022.  Copies of such Notice of Redemption and additional information relating to the procedure for redemption of the Notes may be obtained from the Trustee by calling its Bondholder Communications team at 1-800-934-6802 Monday through Friday from 8 a.m. Central Time to 6 p.m. Central Time or by visiting the Trustee and Paying Agent's website at www.usbank.com/corporatetrust and clicking on the "Bondholder Information" link for redemption instructions.

This announcement is for informational purposes only and does not constitute an offer to buy or a solicitation of an offer to sell, nor shall there be any sale of any of the Notes in any jurisdiction in which the circumstances of such offer, solicitation or sale would be unlawful under the securities laws of any such jurisdiction.

About Albemarle Corporation

ALBemarle Corporation (NYSE: ALB) is a global specialty chemicals company with leading positions in lithium, bromine and catalysts. We think beyond business as usual to power the potential of companies in many of the world's largest and most critical industries, such as energy, electronics, and transportation. We actively pursue a sustainable approach to managing our diverse global footprint of world-class resources. In conjunction with our highly experienced and talented global teams, our deep-seated values, and our collaborative customer relationships, we create value-added and performance-based solutions that enable a safer and more sustainable future.

Forward-Looking Statements

Some of the information presented in this press release, including, without limitation, the Company's ability to complete the redemption and reduce its outstanding indebtedness, and all other information relating to matters that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from the views expressed. Factors that could cause Albemarle's actual results to differ materially from the view expressed or implied in any forward-looking statement include, without limitation: changes in economic and business conditions; changes in financial and operating performance of its major customers and industries and markets served by it; the timing of orders received from customers; the gain or loss of significant customers; market correction in lithium market pricing; changes with respect to contract renegotiations; potential production volume shortfalls; competition from other manufacturers; changes in the demand for its products or the end-user markets in which its products are sold; limitations or prohibitions on the manufacture and sale of its products; availability of raw materials; increases in the cost of raw materials and energy, and its ability to pass through such increases to its customers; technological change and development, changes in its markets in general; fluctuations in foreign currencies; changes in laws and government regulation impacting its operations or its products; the occurrence of regulatory actions, proceedings, claims or litigation (including with respect to the U.S. Foreign Corrupt Practices Act and foreign anti-corruption laws); the occurrence of cyber-security breaches, terrorist attacks, industrial accidents or natural disasters, the effect of climate change, including any regulatory changes to which it might be subject; hazards associated with chemicals manufacturing; the inability to maintain current levels of insurance, including product or premises liability insurance, or the denial of such coverage; political unrest affecting the global economy, including adverse effects from terrorism or hostilities; political instability affecting our manufacturing operations or joint ventures; changes in accounting standards; the inability to achieve results from its global manufacturing cost reduction initiatives as well as its ongoing continuous improvement and rationalization programs; changes in the jurisdictional mix of its earnings and changes in tax laws and rates or interpretation; changes in monetary policies, inflation or interest rates that may impact its ability to raise capital or increase its cost of funds, impact the performance of its pension fund investments and increase its pension expense and funding obligations; volatility and uncertainties in the debt and equity markets; technology or intellectual property infringement, including cyber-security breaches, and other innovation risks; decisions it may make in the future; future acquisition and divestiture transactions, including the ability to successfully execute, operate and integrate acquisitions and divestitures and incurring additional indebtedness; continuing uncertainties as to the duration and impact of the coronavirus (COVID-19) pandemic; performance of Albemarle's partners in joint ventures and other projects; changes in credit ratings; and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under "Risk Factors" in Albemarle's most recent Annual Report on Form 10-K any subsequently filed Quarterly Reports on Form 10-Q. These forward-looking statements speak only as of the date of this press release. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/albemarle-corporation-announces-redemption-of-all-outstanding-4-150-senior-notes-due-2024--301547289.html

SOURCE Albemarle Corporation

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×